Internationalisation

 

Opportunities abound as Saudi Arabia plans $13bn private healthcare expansion

Saudi Arabia’s health ministry is making $13bn (SR48bn) plans for 100 healthcare projects that will involve the private sector. The public-private partnership proposals include constructing two new medical cities, a project to provide 900 beds for medical rehabilitation, and long-term care services, and it looks like foreign investors are actively being courted.

Vivalto Sante goes international with expansion into Portugal and Switzerland

Vivalto Sante, the third largest for-profit hospital group in France, is joining the likes of Fresenius, Ramsay and Mediclinic as it becomes the latest member of the highly select club of multinational hospital groups. As well as having bought a chain of three clinics in Switzerland, it is buying Lusiadas Saude, the third largest hospital group in Portugal. CEO Daniel Caille tells HBI that the decision to go international has nothing to do with opportunities for consolidation within the French market drying up.

Going international is hard for hospital groups

Vivalto Sante has taken the brave step of going international. That is a bold decision for a hospital business based in a single European country. Very few have succeeded in doing this and those that have are top players buying top players. We think of Fresenius Helios buying Quiron in Spain, Ramsay buying Generale de Santé in France and then Capio in Sweden, and Mediclinic buying Hirslanden in Switzerland. 

Major french hospital group moves into Canada

One of the largest French hospital groups has bought two facilities in Quebec where it says it will be able to build and open more for-profit hospitals something that is now impossible in France.

Investment opportunities in UK & Ireland

The UK remains by far the largest market for private equity investment in Europe. But what are the dynamics post-Covid and post-Brexit? A wide-ranging exploration with expert advisors, investors and operators discussing the region’s investment opportunities, growth sectors and regulatory environment. Speakers include: Brian Donley, CEO, Cleveland Clinic London Sharon Lamb, Partner, McDermott Will & […]

2022 Health Care M&A Landscape

2021 has been a record year for deal activity and IPOs. But as multiples hit a ceiling, what will happen in 2022? Investors are keeping a watchful eye on inflation, rising wages, energy bills, and overall increased costs of living. The war in Ukraine, sanctions on Russian companies, particularly oil and gas has only added to market […]

Investing in Europe

What do investors think about key sectors and valuations in Europe? How are concerns about increasing inflation rates impacting valuations? What impact are the ongoing healthcare reforms in the wake of the pandemic having on investment? Speakers include: Martin Henrichs, Managing Director – Head of Healthcare EMEA, UBS Anja Bickelmaier, Co Head of Healthcare, Triton […]

Find Us